"The Tampa Bay Heart Institute at Northside Hospital is now The Tampa Bay Heart Institute at HCA Florida Northside Hospital. We provide advanced diagnostics and treatments for a range of conditions that affect the heart. We provide advanced treatment for heart and vascular conditions such as cardiomyopathy, coronary artery disease, high blood pressure and septal defects. We work hard to bring you exceptional care from consult through recovery, and welcome your questions. To us, the core of good patient care lies in trust and respect between your care team and you. To learn more about our cardiac practice, you can visit our website or call our office directly."

During the past decade, Northside Hospital and Heart Institute conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Northside Hospital and Heart Institute" #1 collaborator was "Abbott Medical Devices" with 1 trials as a collaborator, "Biosense Webster, Inc." with 1 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator and "Procter and Gamble" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Northside Hospital and Heart Institute" are "Arrhythmia" (1 trials), "Atrial Fibrillation" (1 trials), "Coronary Artery Disease" (1 trials) and "Heart Failure" (1 trials). Many other conditions were trialed in "Northside Hospital and Heart Institute" in a lesser frequency.

Most popular intervention types in "Northside Hospital and Heart Institute" are "Device" (2 trials) and "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Left atrial ablation" (1 trials), "Rate or Rhythm Control Therapy" (1 trials), "WiSE System" (1 trials) and "pexelizumab in conjunction with CABG" (1 trials). Other intervention names were less common.

The vast majority of trials in "Northside Hospital and Heart Institute" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Northside Hospital and Heart Institute". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Northside Hospital and Heart Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Northside Hospital and Heart Institute, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".